Viewing Study NCT01161368


Ignite Creation Date: 2025-12-24 @ 5:47 PM
Ignite Modification Date: 2025-12-29 @ 8:23 AM
Study NCT ID: NCT01161368
Status: TERMINATED
Last Update Posted: 2015-08-13
First Post: 2010-05-27
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study Evaluating the Efficacy and Safety of Lapatinib + Vinorelbine in ErbB2 Positive Metastatic Breast Cancer Patients
Sponsor: Central European Cooperative Oncology Group
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2010-09
Start Date Type: None
Primary Completion Date: 2014-05
Primary Completion Date Type: ACTUAL
Completion Date: 2014-05
Completion Date Type: ACTUAL
First Submit Date: 2010-05-27
First Submit QC Date: None
Study First Post Date: 2010-07-13
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2015-08-11
Last Update Post Date: 2015-08-13
Last Update Post Date Type: ESTIMATED